Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftriaxone versus ciprofloxacin for acute bloody diarrhea in children
IRCT20231119060110N1Phase 3Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Dec 2023
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in dysentery and Acute Hemorrhagic Gastroenteritis (AHGE) comparing Intravenous ceftriaxone with Intravenous ciprofloxacin (2 arms). Primary endpoints: Treatment response on day 3, Diarrhea symptoms and 2 more. Started Dec 2023; status: completed.
02
Drugs
ceftriaxoneciprofloxacin
03
Conditions
dysenteryAcute Hemorrhagic Gastroenteritis (AHGE)
Beyond the preview
Go deeper on IRCT20231119060110N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231119060110N1.